Neos Therapeutics Inc (NEOS) - Financial and Strategic SWOT Analysis Review

  • ID: 4278852
  • SWOT Analysis
  • 44 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Contract Pharmacal Corp
  • DPT Laboratories Ltd
  • FibroGen Inc
  • MORE
Neos Therapeutics Inc (NEOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Neos Therapeutics Inc (Neos Therapeutics), formerly Neostx Inc, develops, manufactures, and commercializes branded pharmaceuticals. The company’s portfolio includes Adzenys XR-ODT that is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in patients of six years age and older; and Tussionex that is indicated for cough and upper respiratory symptoms of cold. Its pipeline encompasses investigational candidates for the treatment of ADHD. Neos Therapeutics’ products are orally disintegrating tablets (ODT) or liquid suspension dosage forms, which are based on its proprietary extended-release (XR) drug delivery technology platform. The company also manufactures and markets its generic equivalent of the branded product Tussionex. Neos Therapeutics is headquartered in Grand Prairi, Texas, the US.

Neos Therapeutics Inc Key Recent Developments

Jun 27, 2018: Neos Therapeutics Names Jerry McLaughlin As Chief Executive Officer
May 09, 2018: Neos Therapeutics Reports First Quarter 2018 Financial Results
Mar 15, 2018: Neos Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results
Feb 20, 2018: Neos Therapeutics Reiterates Confidence in Strategic Plan and Value Creation Opportunities
Oct 30, 2017: Neos Therapeutics Board of Directors Unanimously Rejects Unsolicited Proposal from PDL BioPharma

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Contract Pharmacal Corp
  • DPT Laboratories Ltd
  • FibroGen Inc
  • MORE
Section 1 - About the Company
  • Neos Therapeutics Inc - Key Facts
  • Neos Therapeutics Inc - Key Employees
  • Neos Therapeutics Inc - Key Employee Biographies
  • Neos Therapeutics Inc - Major Products and Services
  • Neos Therapeutics Inc - History
  • Neos Therapeutics Inc - Company Statement
  • Neos Therapeutics Inc - Locations And Subsidiaries
  • Head Office
Section 2 - Company Analysis
  • Company Overview
  • Neos Therapeutics Inc - Business Description
  • R&D Overview
  • Neos Therapeutics Inc - Corporate Strategy
  • Neos Therapeutics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Neos Therapeutics Inc - Strengths
  • Neos Therapeutics Inc - Weaknesses
  • Neos Therapeutics Inc - Opportunities
  • Neos Therapeutics Inc - Threats
  • Neos Therapeutics Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Neos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Neos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Neos Therapeutics Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 09, 2018: Neos Therapeutics Reports First Quarter 2018 Financial Results
  • Mar 15, 2018: Neos Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results
  • Feb 20, 2018: Neos Therapeutics Reiterates Confidence in Strategic Plan and Value Creation Opportunities
  • Oct 30, 2017: Neos Therapeutics Board of Directors Unanimously Rejects Unsolicited Proposal from PDL BioPharma
  • Aug 08, 2017: Neos Therapeutics Reports Second Quarter 2017 Financial Results
  • May 09, 2017: Neos Therapeutics Reports First Quarter 2017 Financial Results
  • Mar 14, 2017: Neos Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Neos Therapeutics Inc, Key Facts
  • Neos Therapeutics Inc, Key Employees
  • Neos Therapeutics Inc, Key Employee Biographies
  • Neos Therapeutics Inc, Major Products and Services
  • Neos Therapeutics Inc, History
  • Neos Therapeutics Inc, Key Competitors
  • Neos Therapeutics Inc, Ratios based on current share price
  • Neos Therapeutics Inc, Annual Ratios
  • Neos Therapeutics Inc, Annual Ratios (Cont...1)
  • Neos Therapeutics Inc, Interim Ratios
  • Neos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Neos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Neos Therapeutics Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Neos Therapeutics Inc, Performance Chart (2013 - 2017)
  • Neos Therapeutics Inc, Ratio Charts
  • Neos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Neos Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • FibroGen Inc
  • DPT Laboratories Ltd
  • Contract Pharmacal Corp
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll